Inflammation and heart failure: are we facing a 'hedgehog's dilemma'?
- PMID: 39548817
- DOI: 10.1093/cvr/cvae246
Inflammation and heart failure: are we facing a 'hedgehog's dilemma'?
Conflict of interest statement
Conflict of interest: G.G.C. is coinventors on the International Patent WO/2020/226993 filed in April 2020; the patent relates to the use of antibodies blocking interleukin-1α to reduce various sequelae of ischemia-reperfusion injury to the central nervous system. G.G.C. received financial support by the Alfred and Annemarie von Sick Grants for Translational and Clinical Research Cardiology and Oncology and by the Swiss Heart Foundation, outside the scope of this paper. S.M. has no conflict of interest to disclose.
Comment on
-
Interleukin 11 therapy causes acute left ventricular dysfunction.Cardiovasc Res. 2024 Dec 31;120(17):2220-2235. doi: 10.1093/cvr/cvae224. Cardiovasc Res. 2024. PMID: 39383190 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
